Collegium Pharmaceutical (COLL) Equity Ratio (2014 - 2026)

Collegium Pharmaceutical's Equity Ratio history runs 13 years deep, the most recent figure standing at 0.19 for Q1 2026.

• In Q1 2026, Equity Ratio rose 31.61% year-over-year to 0.19; the TTM figure through Mar 2026 stood at 0.19 (up 31.61% YoY), while the FY2025 annual figure was 0.18, up 32.36% from the prior year.
• Equity Ratio was 0.19 for Q1 2026 at Collegium Pharmaceutical, up from 0.18 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.21 in Q2 2024 to a low of 0.14 in Q4 2024.
• Historically, Equity Ratio has averaged 0.16 across 5 years, with a median of 0.16 in 2022.
• The sharpest annual moves came in 2022 and 2024: Equity Ratio sank 55.25% in 2022, then soared 34.71% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.17 in 2022, then grew by 3.01% to 0.17 in 2023, then declined by 19.53% to 0.14 in 2024, then soared by 32.36% to 0.18 in 2025, then gained by 3.87% to 0.19 in 2026.
• The last three Equity Ratio figures came in at 0.19 (Q1 2026), 0.18 (Q4 2025), and 0.17 (Q3 2025), per Business Quant data.